Julie Brahmer

photo of Julie Brahmer, MD

Associate Professor of Oncology, Johns Hopkins University, School of Medicine

Associate Program Director, Johns Hopkins Clinical Research Network


Julie Brahmer currently serves as an associate professor of oncology at the Johns Hopkins University School of Medicine. She completed her medical training at the University of Nebraska Medical Center, then subsequently completed her fellowship in oncology at the Johns Hopkins School of Medicine.

Dr. Brahmer’s research and clinical practice focuses on the development of new therapies for the treatment and prevention of lung cancer and mesothelioma. Dr. Brahmer has published several papers in this area of research and is a member of the American Society of Clinical Oncology, American Association for Cancer Research, Society for Immunotherapy of Cancer and the Eastern Cooperative Oncology Group (ECOG) Thoracic Committee and Cancer Prevention Steering Committee. She is also on the medical advisory board of the Lung Cancer Research Fund and the Mesothelioma Applied Research Foundation. She serves on the scientific advisory boards of Lungevity, Lung Cancer Foundation of America and Lung Cancer Research Foundation. Dr. Brahmer also serves on the scientific executive committee of Free to Breathe.

Dr. Brahmer currently serves as an associate program director of the Johns Hopkins Clinical Research Network with responsibility for developing clinical trials in oncology within the JHCRN. She plays an active role in collaborating with investigators at JHU and JHCRN affiliated institutions and in communicating with industry sponsors to educate and encourage relationships with the JHCRN. She has also mediated collaborations between other various oncologists at JHU and affiliate institutions which have led to numerous, successful collaborative project efforts thus far.